Name | taraxerol acetate |
---|---|
Synonyms |
Taraxerol monoacetate
3-Picenol, 1,2,3,4,4a,5,6,6a,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-eicosahydro-4,4,6a,8a,11,11,12b,14b-octamethyl-, acetate, (3S,4aR,6aR,8aR,12aR,12bS,14aR,14bR)- Friedoolean-14-en-3-yl acetate D-Friedoolean-14-en-3beta-yl acetate Acetyl taraxerol Taraxerol Acetate Taraxenol acetate (3S,4aR,6aR,8aR,12aR,12bS,14aR,14bR)-4,4,6a,8a,11,11,12b,14b-Octamethyl-1,2,3,4,4a,5,6,6a,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-icosahydro-3-picenyl acetate (3S,4aR,6aR,8aR,12aR,12bS,14aR,14bR)-4,4,6a,8a,11,11,12b,14b-Octamethyl-1,2,3,4,4a,5,6,6a,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-icosahydropicen-3-yl acetate taraxeryl acetate |
Description | Taraxerol acetate is a COX-1 and COX-2 inhibitor with IC50 values of 116.3 μM and 94.7 μM, respectively. Taraxerol acetate the has the anticancer potential and induces cell apoptosis[1]. |
---|---|
Related Catalog | |
Target |
COX-1:116.3 μM (IC50) COX-2:94.7 μM (IC50) |
In Vitro | Taraxerol acetate(10-150 µM; 24 or 48 hours) induces a dose- and time-dependent cytotoxic effects in the U87 cells, exhibits IC50 values of 34.2 and 28.4 µM, at 24 and 48 h, respectively[2]. Taraxerol acetate(10, 50 and 150 µM; 24 hours) induces cell apoptosis, the percentage of apoptotic cells increased from 7.3% in the control cells, to 16.1, 44.1 and in the 10, 50 and 150 µM taraxerol acetate-treated cells, respectively. Furthermore, taraxerol acetate treatment led to sub-G1 cell cycle arrest with a corresponding decrease in the number of S-phase cells[2]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 505.1±49.0 °C at 760 mmHg |
Melting Point | 303-305ºC |
Molecular Formula | C32H52O2 |
Molecular Weight | 468.754 |
Flash Point | 256.2±17.4 °C |
Exact Mass | 468.396729 |
PSA | 26.30000 |
LogP | 11.95 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.529 |
Hazard Codes | Xi |
---|